# DOMENICA (NCT05201547)

> Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05201547
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: ARCAGY/ GINECO GROUP
- Conditions: Endometrial Cancer
- Interventions: Carboplatin-Paclitaxel; Dostarlimab
- Enrollment: 260
- Primary outcome: Progression Free Survival (PFS)

## Commentary we found

- YouTube: 27
- Podcasts: 20
- X threads: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=domenica-nct05201547

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05201547", "email": "<work email>"}; the inbox owner confirms by the emailed link.